Abstract
Lumbar discectomy is considered a safe, efficacious and cost-effective treatment for selected cases of patients with leg pain associated with the presence of a disc protrusion, but despite technically successful surgery, 30% of patients complain of persistent pain on long-term follow up. Identification of possible predictors for a negative outcome is important, in the search for appropriate pre-and/or post-operative care and prevention of persistent disability. There is some evidence in the literature that quantitative sensory testing (QST) measures may play a role in prediction of patients' pain persistency, however, this has never been investigated in patients undergoing lumbar discectomy.
The aim of this study is to determine the predictive value of QST parameters, in combination with previously documented predictor variables such as medical/psychological/cognitive behavioural factors, in patients with lumbar radiculopathy and/or radicular pain, for predicting patients' clinical outcome after lumbar discectomy.
Participants with radiculopathy and/or radicular pain and confirmed imaging diagnosis of nerve root compression will be recruited from the elective surgery waitlist at one hospital.
All participants will undergo lumbar discectomy performed by one neurosurgeon. A standardized QST protocol comprising all of the somatosensory sub-modalities that are mediated by different primary afferents (C-, Aδ-, Aβ-) will be performed prior to surgery.
QST will be conducted in the patients' main pain area and contralateral side, in the affected dermatome and at a remote control site. The presence of other predictor variables will be captured by questionnaires. Follow-up at 3 months will include QST and measurements of pain intensity, pain descriptors, functional status, health related quality of life, return to work and health care utilisation. A further 1-year follow-up will include the same measurements except QST.
Identification of new predictor variables may assist in the development of pre-surgical screening methods and in targeted pre-and/or post-operative patient care, with the potential to improve patients' functional status, quality of life, work capacity whilst also reducing health care costs associated with persistent disability.
INTRODUCTION
Low back pain is one of the most common health problems and affects 80 -85% of people over their life time [36] . Low back-related leg pain or sciatica, characterised by radiating pain that follows a dermatomal pattern [53] ,is a common variation of LBP. The prevalence of sciatic symptoms in the general population ranges from 1.2% to 43% in the literature [29] . Although the prognosis is good in most patients, up to 30% of patients continue to have pain for 1 year or longer [54; 56] .
Sciatia is most frequently caused by a nerve root compression due to disc herniation [54] and can be accompanied by signs of a nerve root lesion, such as neurological sensory or motor deficits. Patients with sciatica are likely to present with nociceptive as well as neuropathic pain (defined as 'pain caused by a lesion or disease of the somatosensory nervous system' [26] ). Neuropathic pain has been shown to be associated with greater pain severity, increased suffering, increased disability, more impaired quality of life and greater health care costs than purely nociceptive low-back related leg pain [16; 43; 44; 45] .
Lumbar discectomy is considered a cost-effective treatment for selected cases of patients with leg pain associated with the presence of a disc protrusion [19] , but despite technically successful surgery, 30% of patients complain of persistent pain on long-term follow up [10] which is associated with substantial health care costs [38] and reduced work capacity [9] .
Numerous risk factors and predictors for a negative outcome of disc surgery have been identified [32] , including pain history [34] , diagnosis specific clinical features such as size of disc herniation, Lasègue sign [28] , pre-surgical intake of medication and poor functional status [37] , psychological and cognitive-behavioural factors such as fear avoidance behaviour and negative outcome expectancy [8; 9; 27] , pain catastrophizing [30] , depression and anxiety [7; 13; 28] . However, it is not possible to identify an unequivocal predictor due to interactions between several risk factors, large variances in study designs, patient clinical profiles and used outcome measures [32] .
An additional approach to explore predictive factors for pain persistency may lie in the investigation of sensory parameters, measured by quantitative sensory testing (QST).
QST has been widely used to obtain reliable quantitative measures of large and small sensory nerve fibre dysfunction, manifesting as presence of sensory loss and/or cold and pressure pain thresholds predicted pain-related disability after 6 months in this cohort [30] . Furthermore, cold hyperalgesia measured in patients in the acute stage after sustaining a whiplash injury was a significant predictor of poor outcome at long-term follow up [49] .
QST data on patients with lumbar radiculopathy/sciatica are scarce. QST has been employed in this population in the affected dermatomal area to assess the function of sensory nerve fibers [17; 35; 59] and the recovery of nerve fiber function after lumbar decompression [33] . Preoperative loss of C-fibre function (measured by warm detection thresholds) was documented as negative predictive factor for lumbar microdiscectomy in 39 patients undergoing surgical decompression [33] . However, no study to date has established the QST sensory profile of this patient cohort in relation to their main pain area, as is required for the assessment of neuropathic pain [21] and as proposed for the current study.
There is some evidence that some sensory fibre populations may be more effected by nerve root compression than others [17; 46] and that the difference in the extent of sensory fibre loss may account for variability of resulting symptoms such as sensory loss and/or enhanced pain sensitivity [24] . This may explain the identification of sub-groups of patients with differing sensory profiles, as observed in patients with cervical radiculopathy [52] and as documented in a large epidemiological study on 2094 patients with painful lumbar radiculopathy [31] . The identification of sub-groups in the latter study was based on pain descriptors of a neuropathic pain screening tool (painDETECT) [15] .
It is postulated that differences in sensory profiles and underlying pain mechanisms may account for differences in responsiveness to pharmaceutical intervention targeting neuropathic pain associated with radiculopathy [3; 6; 43], and may account for differences in clinical outcome after discectomy. The proposed study will provide further insight into the underlying pain mechanisms in a patient population undergoing surgical treatment.
OBJECTIVES
The overall aim of this project is to determine the predictive value of somatosensory characteristics in participants with lumbar radiculopathy/radicular pain, for predicting participants' clinical outcome after lumbar discectomy. Somatosensory characteristics will be explored using QST. Specific aims are:
i.
To establish the QST somatosensory profile of participants with lumbar radiculopathy/radicular pain before and after surgery
ii.
To investigate if there is an association between pre-surgical QST parameters and clinical outcome (functional status, pain intensity,health-related quality of life (HRQoL), return to work, confidence in recovery, health care utilisation, global perceived impression of change, bothersomeness) after lumbar microdiscectomy Hypotheses:
1. There will be sub-groups of participants with differing somatosensory profiles before surgery.
2. There will be a difference in QST profiles between participants with and without persistent pain after surgery. The Oswestry Disability Index (ODI) will be used as primary outcome measure after surgery. The scoring of ODI is between 0-100 (100 maximum disability).
10 points or 30% score improvement is the cut-off point for minimal important change [48] . A sample size of 40 participants is required to detect 10 units pre-post surgery with a power of 80% and 5% level of significance.
The inclusion criteria for the symptomatic participants will be as follows: age 18 to 65 years; symptom duration of > 3 months; clinical diagnosis of lumbar radiculopathy (defined as conduction block along a spinal nerve or nerve root, manifesting clinically with dermatomal sensory loss or myotomal weakness or reflex changes [5] ) and leg pain in L5 or S1 dermatomal distribution; demonstrable clinically relevant abnormality on imaging studies indicating nerve root compression at the relevant spinal level; person listed on the elective neurosurgery surgery waitlist for the procedure of lumbar discectomy.
Exclusion criteria include diabetes and vascular disease (i.e. any disease affecting the vascular system and potentially affecting the sensation testing in any of the body regions to be assessed, e.g. Raynaud's disease, peripheral arterial disease; other neurological or psychiatric disease; previous lumbar surgery; a history of any disorders that potentially might affect the sensation in the hand (negative control site) to be tested and an insufficient level of English to understand and fill out the questionnaires. Each participant must be able to understand the instructions/requirements for the quantitative sensory testing procedures and be able to give a reliable response that does not depend on translation and is not vulnerable to misinterpretation.
Reference data from healthy control subjects (HC) will be obtained in order to compare if symptomatic participants differ from a healthy cohort. HCs will be matched for age and gender to the symptomatic participant groups and will be recruited from the local community. Subjects with a history of current pain or a chronic pain condition or any of the exclusion criteria described for the symptomatic participant group will be excluded, including taking medications that influence pain perception (e.g. analgesics, nonsteroidals, antidepressants). The number of HC subjects to be tested has to be determined during the course of the study, as reference data have to be obtained from at least 8 male and 8 female HC subjects [4] for each maximal pain area nominated by the symptomatic participants. The minimum number of 8 is based on recommendations of the DNFS and their published methodology [4] . Participants with either L5 or S1 radicular pain will be included in the study, hence it is anticipated that 4 body regions may be nominated as maximal pain area (thigh L5 and S1 distribution, lower leg L5 and S1 distribution).
Testing protocol
The initial patient assessment will take approximately 2.5 hours. The participant's pain history, including pain distribution and pain behaviour will be recorded and a clinical examination for determination of neurological deficits will be conducted (reflex, strength and sensation testing).
The following measurements will be taken either in interview format or via questionnaires. Finally QST will be performed.
• Duration of pain (part of Örebro Musculoskeletal Screening Questionnaire (Short form) [18] • Pain intensity of back and leg pain (11-point numerical rating scale (NRS)
• Health care utilisation
• Bothersomeness of back and leg pain
• Confidence in recovery ('great deal', 'moderate', 'no confidence', 'do not know')
[37]
• Intake of medication
• Sleep quality (Visual Analogue Scale) [52] • Duration of inability to work
• Functional status (Oswestry Disability Index) [14] • Anxiety and Depression (Hospital Anxiety and Depression Scale) (HADS) [23] • Pain descriptors (painDETECT) [15] • Fear avoidance behaviour (Tampa Scale for Kinesiophobia) [51] • Pain catastrophizing (Pain catastrophizing Scale) [50] • Health-related quality of life (Short form-36 health questionnaire) (SF-36v2®) [55] • Risk assessment for persistent pain (Örebro Musculoskeletal Screening Questionnaire) (Short form) [18] The degree of nerve root compression [39] will be determined by a neurosurgery registrar who is blind to the participant's enrolment into the study.
HC participants will complete the HADs and SF 36 questionnaire and their sleep quality will be determined.
Quantitative sensory testing
Standardized QST will be performed according to the QST protocol of DFNS [41; 42] .
The protocol includes the following assessments: cold and warm detection thresholds,
;he number of paradoxical heat sensations during the procedure of alternating warm and cold stimuli; cold and heat pain thresholds; mechanical detection threshold; mechanical pain threshold; stimulus-response functions: mechanical pain sensitivity and dynamic mechanical allodynia; wind-up ratio; vibration detection threshold and pressure pain threshold.
QST measurements will be taken from the main pain area nominated by the symptomatic participant, as required for the assessment of neuropathic pain [21] and the contralateral side [21] and from the ipsilateral hand dorsum as a remote control site, plus thermal and mechanical detection thresholds will be assessed in the relevant dermatome (L5, S1) on the symptomatic side. Testing sites in HC subjects will be matched to the sites tested in symptomatic participant. Testing of the full QST protocol will take approximately 30 minutes per test area. Testing of dermatomal detection thresholds will take less than 10 minutes.
Outcome assessment 3 months postoperatively
• Functional status Oswestry [14] • Pain intensity
• Pain descriptors [15] • Health-related quality of life [55] • Return to work (yes/no)
• Medication intake
• Patient Global Impression of Change Scale [12] • Bothersomenes of back and leg pain
• QST in previously tested maximal pain area and dermatome (appr. 40 minutes)
The assessment will take approximately one hour.
Outcome assessment 1 year postoperatively:
The same questionnaires as at 3 months will be mailed to the participants.
Statistical analysis
QST data will be log-transformed prior to statistical analysis except those data which are normally distributed as raw data [42] . To compare and illustrate participants' QST data profiles with the group mean of age/gender matched healthy controls particpants' data will be z-transformed for each single parameter by using the following expression: Zscore = (Mean single proband -Mean healthy controls )/SD healthy controls [42] . Z-values will be calculated based on the HC group data.
Differences of z-score QST data between the symptomatic participant group and HC and tested body regions will be compared using a two-way analysis of covariance (ANCOVA) with tested body areas (maximal pain area, hand) as the within-subjects factor. Group (participants/controls) will be entered as between-subjects factors. Anxiety, depression and fear avoidance scores will be entered as covariates to account for potential influence of these factors on pain responses [40] . Depending on data distribution, differences of some predictor variables (Oswestry Disability Index [14] , HADS [23] ,Tampa Scale for Kinesiophobia [51] , SF-36v2® [55] ) between patients and HC will be compared using parametric (t-Test) or non-parametric tests (Mann-Whitney-U test).
Differences in outcome measures pre-and post-surgery will be compared using repeated measures ANOVA in case of normal distribution of variables, and the Friedman's Test for non-normal distributed data. Multivariate regression analyses will be performed to assess associations between the predictor variables, QST measures and the outcome variables.
